Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03396341
What this trial is testing

Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes

Who this might be right for
Genetic TestingBRCA1/2
Memorial Sloan Kettering Cancer Center 806
Post-approval studies (Phase 4)UnknownNCT01698177
What this trial is testing

Optimizing Influenza Vaccination in Surgical Oncology Patients

Who this might be right for
Influenza
Stony Brook University 204
Testing effectiveness (Phase 2)Study completedNCT01340430
What this trial is testing

Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Lucia Del Mastro,MD 43
Not applicableStudy completedNCT01135875
What this trial is testing

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma MultiformeHealthy Volunteers
University of Florida 130
Post-approval studies (Phase 4)Study completedNCT02567331
What this trial is testing

Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 28
Not applicableStudy completedNCT03526328
What this trial is testing

DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma

Who this might be right for
Barrett's EsophagusEsophageal Adenocarcinoma
University of Oklahoma 32
Not applicableEnded earlyNCT02837757
What this trial is testing

Everolimus Modulation of Anti-tumor T CD4 Immune Responses

Who this might be right for
Metastatic Renal Cancer
Centre Hospitalier Universitaire de Besancon 14
Very early researchLooking for participantsNCT04135807
What this trial is testing

Implantable Microdevice In Primary Brain Tumors

Who this might be right for
Grade II GliomaGrade III GliomaGrade IV Glioma+5 more
Oliver Jonas 12
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Testing effectiveness (Phase 2)Looking for participantsNCT07757165
What this trial is testing

The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy

Who this might be right for
Advanced Metastatic Gastric Cancer
Fudan University 126
Not applicableEnded earlyNCT02071719
What this trial is testing

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

Who this might be right for
Renal Cell Cancer
M. Labots 6
Not applicableLooking for participantsNCT03387865
What this trial is testing

A Clinico-biological Database of Lung Cancers

Who this might be right for
Lung Cancer
University Hospital, Lille 500
Early research (Phase 1)Looking for participantsNCT06044857
What this trial is testing

PSMA PET Response Guided SabR in High Risk Pca

Who this might be right for
Prostate Adenocarcinoma
University of Texas Southwestern Medical Center 20
Not applicableWithdrawnNCT00934401
What this trial is testing

Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
University of Iowa
Not applicableStudy completedNCT04710212
What this trial is testing

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyLeukemia, AcuteNeutropenia+1 more
Duke University 168
Testing effectiveness (Phase 2)Ended earlyNCT00551759
What this trial is testing

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 22
Not applicableStudy completedNCT01120262
What this trial is testing

S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 545
Post-approval studies (Phase 4)Study completedNCT03252223
What this trial is testing

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

Who this might be right for
Polycystic Ovary SyndromeHealthyAnovulation+1 more
University of California, San Diego 33
Not applicableUnknownNCT04878796
What this trial is testing

Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)

Who this might be right for
CancerCovid-19Vaccine Response
Azienda Socio Sanitaria Territoriale di Cremona 300
Not applicableLooking for participantsNCT06061705
What this trial is testing

Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Fondation Hôpital Saint-Joseph 100
Next Page